{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:01:11Z","timestamp":1773284471093,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.042","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T10:49:55Z","timestamp":1540378195000},"page":"521","source":"Crossref","is-referenced-by-count":3,"title":["Is Management of Central Retinal Artery Occlusion the Next Frontier in Cerebrovascular Diseases?"],"prefix":"10.1016","volume":"28","author":[{"given":"Kaustubh","family":"Limaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Harold P.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0001","doi-asserted-by":"crossref","first-page":"30321","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.006","article-title":"Is management of centralretinal artery occlusion the next frontier in cerebrovascular diseases?","volume":"27","author":"Limaye","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00417-006-0473-5","article-title":"Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications","volume":"245","author":"Hayreh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00417-006-0488-y","article-title":"Response to comment: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE-Group) for the treatment of central retinal artery occlusion: design issues and implications","volume":"245","author":"Feltgen","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of reteplase with alteplase for acute myocardial infarction","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0006","first-page":"1581","article-title":"The National Institute of Neurological Disorders and Stroke rt-PA stroke study group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0007","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0008","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0009","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.09.042_bib0010","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1016\/j.ophtha.2016.09.024","article-title":"Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae","volume":"124","author":"Olsen","year":"2017","journal-title":"Ophthalmology"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718305640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718305640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T19:37:08Z","timestamp":1548272228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718305640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1052305718305640"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.09.042","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}